Literature DB >> 28435092

(-)-Terpinen-4-ol changes intracellular Ca2+ handling and induces pacing disturbance in rat hearts.

Antonio Nei Santana Gondim1, Aline Lara2, Artur Santos-Miranda3, Danilo Roman-Campos4, Sandra Lauton-Santos5, José Evaldo Rodrigues Menezes-Filho5, Carla Maria Lins de Vasconcelos5, Eduardo Antonio Conde-Garcia5, Silvia Guatimosim2, Jader S Cruz6.   

Abstract

(-)-Terpinen-4-ol is a naturally occurring plant monoterpene and has been shown to have a plethora of biological activities. The objective of this study was to investigate the effects of (-)-terpinen-4-ol on the rat heart, a key player in the control and maintenance of arterial blood pressure. The effects of (-)-terpinen-4-ol on the rat heart were investigated using isolated left atrium isometric force measurements, in vivo electrocardiogram (ECG) recordings, patch clamp technique, and confocal microscopy. It was observed that (-)-terpinen-4-ol reduced contraction force in an isolated left atrium at millimolar concentrations. Conversely, it induced a positive inotropic effect and extrasystoles at micromolar concentrations, suggesting that (-)-terpinen-4-ol may have arrhythmogenic activity on cardiac tissue. In anaesthetized animals, (-)-terpinen-4-ol also elicited rhythm disturbance, such as supraventricular tachycardia and atrioventricular block. To investigate the cellular mechanism underlying the dual effect of (-)-terpinen-4-ol on heart muscle, experiments were performed on isolated ventricular cardiomyocytes to determine the effect of (-)-terpinen-4-ol on L-type Ca2+ currents, Ca2+ sparks, and Ca2+ transients. The arrhythmogenic activity of (-)-terpinen-4-ol in vitro and in vivo may be explained by its effect on intracellular Ca2+ handling. Taken together, our data suggest that (-)-terpinen-4-ol has cardiac arrhythmogenic activity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (-)-Terpinen-4-ol; (-)-Terpinen-4-ol (PubChem CID: 5325830); Alpinia zerumbet; Arrhythmia; Ca(2+) current; Cardiac myocytes; Heart

Mesh:

Substances:

Year:  2017        PMID: 28435092     DOI: 10.1016/j.ejphar.2017.04.022

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Redox-Active Drug, MnTE-2-PyP5+, Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function.

Authors:  Andrezza M Barbosa; José F Sarmento-Neto; José E R Menezes Filho; Itamar C G Jesus; Diego S Souza; Valério M N Vasconcelos; Fagner D L Gomes; Aline Lara; Juliana S S Araújo; Sandra S Mattos; Carla M L Vasconcelos; Silvia Guatimosim; Jader S Cruz; Ines Batinic-Haberle; Demetrius A M Araújo; Júlio S Rebouças; Enéas R Gomes
Journal:  Oxid Med Cell Longev       Date:  2020-03-21       Impact factor: 6.543

2.  Bradycardic and Antiarrhythmic Effects of the D-Limonene in Rats.

Authors:  Gildenisson Araújo do Nascimento; Diego Santos de Souza; Bruno Santos Lima; Carla Maria Lins de Vasconcelos; Adriano Antunes de Souza Araújo; Aimée Obolari Durço; Lucindo José Quintans-Junior; Jackson Roberto Guedes da Silva Almeida; Aldeída Pereira Oliveira; Valter Joviniano de Santana-Filho; André Sales Barreto; Márcio Roberto Viana Dos Santos
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

3.  Where are We Going with Natural Products? Exploring the True Potential of New Plant-Based Drugs in the Cardiovascular Field.

Authors:  Artur Santos-Miranda
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667

4.  Quality Control of Oleum Cinnamomi Assisted by Network Pharmacology Strategy.

Authors:  Lin Zheng; Yang Zhou; Ting Yan; Zipeng Gong; Yueting Li; Siying Chen; Yong Huang; Mingyan Chi
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.